Researchers have found that antibodies do not need a particular sugar attachment long believed to be essential to their function, a discovery that could make producing therapeutic antibodies much easier and cheaper in the future. more...
The power of massive, integrated programs must be brought to bear. more...
Mammalian cells with extra chromosomes share some common traits that could be exploited to develop cancer treatments, according to MIT biologists. more...
In Cell, KI researcher describe how computer simulations can reveal the inner workings and vulnerabilities of a cancer. The results reveal new ways in which cells process chemical information and could indicate how to maximize the effectiveness of disease treatments such as chemotherapy. more...
Koch Institute plays important role in uncovering why people react differently to chemotherapy. more...
KI's integrative research approach highlighted as a leading example. more...
New MEMS chip for cell sizing seen as revolutionary science. more...
KI researchers describe potent immuno-suppressive activity of prostate cancer microenvironment. more...
Alnylam and KI collaborators publish new research on RNAi mediated gene silencing of PCSK9, a genetically validated regulator of LDL metabolism. more...
MIT engineers and biologists seek to optimize potential treatments. more...
Published in Science, KI researcher define novel changes in 3'UTR and microRNAs in cancer cells. more...
MIT Institute Professor Robert Langer has won the Millennium Technology Prize, the world's largest award for technology innovation. more...
A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis. more...
Snippets of genetic material that have been linked to cancer also play a critical role in normal embryonic development in mice, according to a new paper from MIT cancer biologists. more...
MIT broke ground on Friday for the new David H. Koch Institute for Integrative Cancer Research, a facility that its director, Tyler Jacks, said will usher in "the next generation in cancer research." more...
